Semaglutide is often chosen first if cost is a major barrier, if insurance covers it more reliably, or if someone is nervous about potentially stronger gastrointestinal side effects, and it has a long track record in both diabetes and chronic weight management, so clinicians may start there for a conservative yet effective approach, especially for modest weight loss goals, then consider switching to tirzepatide later if results plateau, side effects remain manageable, and coverage improves, and some practices even map out this stepwise plan during the very first visit
This GLP-1 secretion assay, suitable for compound profiling studies , has been functionally validated using carbohydrate stimuli
Approved Uses The FDA has approved Ozempic and Wegovy for: Type 2 Diabetes Management: Helps control blood sugar when diet and exercise arent enough
one study found a 40 percent reduction in antibodies in people with Hashimotos, with three to six months of therapeutic doses of selenium